Bengt Tholander

2.3k total citations
43 papers, 1.4k citations indexed

About

Bengt Tholander is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Bengt Tholander has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Reproductive Medicine, 12 papers in Oncology and 12 papers in Obstetrics and Gynecology. Recurrent topics in Bengt Tholander's work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Intraperitoneal and Appendiceal Malignancies (6 papers). Bengt Tholander is often cited by papers focused on Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Intraperitoneal and Appendiceal Malignancies (6 papers). Bengt Tholander collaborates with scholars based in Sweden, Netherlands and United Kingdom. Bengt Tholander's co-authors include Thomas Högberg, Per Rosenberg, Peter Nygren, Rolf Larsson, Hans Ericsson, C G Regårdh, K Csóka, Giovanni Scambia, Germana Tognon and Seija Grénman and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Bengt Tholander

43 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bengt Tholander Sweden 21 735 551 335 331 270 43 1.4k
Leigh G. Seamon United States 22 955 1.3× 973 1.8× 313 0.9× 255 0.8× 557 2.1× 49 1.8k
Keiichiro Nakamura Japan 28 546 0.7× 813 1.5× 606 1.8× 495 1.5× 251 0.9× 105 2.1k
Lisa Barroilhet United States 21 393 0.5× 357 0.6× 216 0.6× 356 1.1× 162 0.6× 62 1.1k
K. Sjövall Sweden 23 728 1.0× 339 0.6× 546 1.6× 315 1.0× 406 1.5× 44 1.9k
G.J.S. Rustin United Kingdom 21 870 1.2× 276 0.5× 455 1.4× 450 1.4× 731 2.7× 56 1.9k
Aliza Leiser United States 13 301 0.4× 213 0.4× 335 1.0× 433 1.3× 112 0.4× 29 1.2k
Jérôme Alexandre France 20 369 0.5× 266 0.5× 823 2.5× 360 1.1× 302 1.1× 100 1.7k
G. Favalli Italy 19 1.9k 2.5× 1.0k 1.8× 606 1.8× 293 0.9× 1.3k 4.7× 45 2.7k
S. Stephen United States 12 235 0.3× 364 0.7× 327 1.0× 188 0.6× 86 0.3× 21 1.1k
Cem Önal Türkiye 24 206 0.3× 482 0.9× 375 1.1× 264 0.8× 373 1.4× 178 2.0k

Countries citing papers authored by Bengt Tholander

Since Specialization
Citations

This map shows the geographic impact of Bengt Tholander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bengt Tholander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bengt Tholander more than expected).

Fields of papers citing papers by Bengt Tholander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bengt Tholander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bengt Tholander. The network helps show where Bengt Tholander may publish in the future.

Co-authorship network of co-authors of Bengt Tholander

This figure shows the co-authorship network connecting the top 25 collaborators of Bengt Tholander. A scholar is included among the top collaborators of Bengt Tholander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bengt Tholander. Bengt Tholander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marcickiewicz, Janusz, Christer Borgfeldt, Maria Bjurberg, et al.. (2021). Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer—A Swedish Gynecologic Cancer Group (SweGCG) study. Acta Obstetricia Et Gynecologica Scandinavica. 100(8). 1526–1533. 23 indexed citations
2.
Borgfeldt, Christer, Erik Holmberg, Janusz Marcickiewicz, et al.. (2021). Survival in endometrial cancer in relation to minimally invasive surgery or open surgery – a Swedish Gynecologic Cancer Group (SweGCG) study. BMC Cancer. 21(1). 658–658. 6 indexed citations
3.
Tholander, Bengt, Birgitta Grundmark, Stefan Cajander, et al.. (2013). Chemotherapeutic drug sensitivity of primary cultures of epithelial ovarian cancer cells from patients in relation to tumour characteristics and therapeutic outcome. Acta Oncologica. 53(2). 242–250. 7 indexed citations
4.
González-Martı́n, Antonio, Laurence Gladieff, Bengt Tholander, et al.. (2013). Efficacy and safety results from OCTAVIA, a single-arm phase II study evaluating front-line bevacizumab, carboplatin and weekly paclitaxel for ovarian cancer. European Journal of Cancer. 49(18). 3831–3838. 43 indexed citations
5.
Colombo, Nicoletta, Giorgia Mangili, Serafina Mammoliti, et al.. (2011). A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites. Gynecologic Oncology. 125(1). 42–47. 69 indexed citations
6.
Högberg, Thomas, Mauro Signorelli, Carlos Oliveira, et al.. (2010). Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – Results from two randomised studies. European Journal of Cancer. 46(13). 2422–2431. 313 indexed citations
7.
Colombo, N., Giorgia Mangili, Serafina Mammoliti, et al.. (2008). Aflibercept (VEGF Trap) for advanced epithelial ovarian cancer (EOC) patients (pts) with symptomatic malignant ascites: Preliminary results of a pilot study. Journal of Clinical Oncology. 26(15_suppl). 14598–14598. 19 indexed citations
8.
Mahteme, Haile, Birgitta Grundmark, Bengt Tholander, et al.. (2007). Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis. European Journal of Surgical Oncology. 34(5). 547–552. 20 indexed citations
9.
Petris, Luigi De, Kjell Bergfeldt, Christina Hising, et al.. (2004). Correlation between HLA-A2 Gene Frequency, Latitude, Ovarian and Prostate Cancer Mortality Rates. Medical Oncology. 21(1). 49–52. 29 indexed citations
10.
Berglund, Åke, Bengt Glimelius, Jonas Bergh, et al.. (2002). Selection of Chemotherapy by Ex Vivo Assessment of Tumor Sensitivity to Cytotoxic Drugs: Results of a Clinical Trial. Medical Oncology. 19(3). 151–160. 8 indexed citations
11.
Friberg, Lena E., Mats O. Karlsson, Saadia Hassan, et al.. (2001). In vivo activity of CHS 828 on hollow-fibre cultures of primary human tumour cells from patients. Cancer Letters. 162(2). 193–200. 19 indexed citations
12.
Ericsson, Hans, Bengt Tholander, & C G Regårdh. (1999). In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. European Journal of Pharmaceutical Sciences. 8(1). 29–37. 53 indexed citations
13.
Tholander, Bengt, et al.. (1997). In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA). International Journal of Cancer. 72(6). 1008–1012. 30 indexed citations
14.
Nygren, Peter, K Csóka, Bertil Jönsson, et al.. (1995). The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL. British Journal of Cancer. 71(3). 478–481. 43 indexed citations
15.
16.
Tholander, Bengt, et al.. (1992). Immunohistochemical detection of CA-125 and carcinoembryonic antigen in ovarian tumors in relation to corresponding preoperative serum levels. International Journal of Gynecological Cancer. 2(5). 263–270. 9 indexed citations
17.
Tholander, Bengt, et al.. (1992). Tissue expression of CA-125 and carcinoembryonic antigen in ovarian carcinoma in relation to nuclear DNA content, histologic grade, and patient survival. International Journal of Gynecological Cancer. 2(5). 271–279. 3 indexed citations
18.
19.
20.
Stendahl, U, et al.. (1989). Expression of Placental Alkaline Phosphatase in Epithelial Ovarian Tumours. Tumor Biology. 10(3). 126–132. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leigh G. Seamon Breakdown of academic impact, for papers by Keiichiro Nakamura Breakdown of academic impact, for papers by Lisa Barroilhet Breakdown of academic impact, for papers by K. Sjövall Breakdown of academic impact, for papers by G.J.S. Rustin Breakdown of academic impact, for papers by Aliza Leiser Breakdown of academic impact, for papers by Jérôme Alexandre Breakdown of academic impact, for papers by G. Favalli Breakdown of academic impact, for papers by S. Stephen Breakdown of academic impact, for papers by Cem Önal
Rankless by CCL
2026